ArticleThe American journal of cardiology2023

Comparison of Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Prescribing in Patients With Diabetes Mellitus With and Without Cardiovascular Disease.

Hawkins C Gay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.